Novartis hits pause on Fovista agreement (OPHT) 

Novartis hits pause on Fovista agreement

Novartis hits pause on Fovista agreement

Due to lack of effectiveness shown so far for treatment of anti pdgf in combo with anti vegf in wet amd. 

http://www.biopharmadive.com/news/novartis-ophthotech-fovista-licensing-letter-agreement/446712/

Leave a Reply

Your email address will not be published. Required fields are marked *